Market Size of Japan Self-Monitoring Blood Glucose Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 663.13 Million |
| Market Size (2029) | USD 851 Million |
| CAGR (2024 - 2029) | 5.60 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Japan Self-Monitoring Blood Glucose Devices Market Analysis
The Japan Self-Monitoring Blood Glucose Devices Market size is estimated at USD 663.13 million in 2024, and is expected to reach USD 851 million by 2029, growing at a CAGR of 5.60% during the forecast period (2024-2029).
Blood glucose monitoring increases patients' awareness of glucose values, which supports healthy lifestyle choices. Blood glucose monitoring values help provide feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.
Innovative technologies, such as digital health apps that display and summarize individual blood glucose measurements and incorporate additional relevant data such as insulin doses, meals and snacks, and physical activity, can further support self-management while decreasing disease burden and benefiting overall diabetes care. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes with the additional support needed to improve critical outcomes, thereby enhancing market prospects in the years to come.
The World Health Assembly Resolution recommended the integration of prevention and treatment of diabetes into primary health services, the development of pathways for a substantial increase in access to insulin, the promotion of convergence and harmonization of regulatory requirements for diabetes medicines and technologies, and improved diabetes monitoring and surveillance. Furthermore, it involves the WHO advising the Member States to ensure the uninterrupted treatment of people living with diabetes in humanitarian emergencies. This important milestone provides a global mandate for diabetes efforts for the next decade.
Therefore, the studied market is anticipated to witness growth over the analysis period due to rising prevalence and the aforementioned factors.
Japan Self-Monitoring Blood Glucose Devices Industry Segmentation
Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The Japanese self-monitoring blood glucose device market is segmented by components. The report offers the value (in USD) and volume (in units) for the above segments.
| Component | |
| Glucometer Devices | |
| Test Strips | |
| Lancets |
Japan Self-Monitoring Blood Glucose Devices Market Size Summary
The Japan self-monitoring blood glucose devices market is poised for significant growth over the forecast period, driven by the increasing prevalence of diabetes and the aging population. As diabetes becomes a global epidemic, Japan's large elderly demographic is particularly susceptible to type-2 diabetes, necessitating effective monitoring and management of blood glucose levels. The market is characterized by the adoption of innovative technologies, such as digital health apps and automated insulin titration software, which enhance self-management and improve health outcomes. These advancements are supported by global health initiatives, including the World Health Assembly's recommendations, which emphasize the integration of diabetes prevention and treatment into primary health services. The Japanese healthcare system also plays a crucial role, with public awareness campaigns and disease management programs aimed at reducing the incidence of adult-onset diabetes.
The market landscape is fragmented, with key players like Abbott, LifeScan, and Roche holding significant shares. The test strip segment dominates the market due to its recurring use and essential role in blood glucose testing. The economic burden of diabetes, exacerbated by comorbidities and complications, underscores the importance of well-organized medical insurance systems that cover diabetes-related medical fees. Recent developments, such as Astellas Pharma's collaboration with Roche Diabetes Care and Quantum Operation Inc.'s non-invasive glucose monitor, highlight the ongoing innovation in the sector. These efforts are expected to further drive market growth, as they offer advanced solutions for diabetes management and align with the country's healthcare priorities.
Japan Self-Monitoring Blood Glucose Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Component
-
2.1.1 Glucometer Devices
-
2.1.2 Test Strips
-
2.1.3 Lancets
-
-
Japan Self-Monitoring Blood Glucose Devices Market Size FAQs
How big is the Japan Self-Monitoring Blood Glucose Devices Market?
The Japan Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 663.13 million in 2024 and grow at a CAGR of 5.60% to reach USD 851 million by 2029.
What is the current Japan Self-Monitoring Blood Glucose Devices Market size?
In 2024, the Japan Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 663.13 million.
